Cephalon News
Most Popular Cephalon Story
Cephalon aims Nuvigil at depression
Cephalon won't let Provigil go gently into that post-patent night. Already, the drugmaker has readied its follow-up: Nuvigil, an extended release form of the stay-awake drug. Like Effexor and Effexor Read more...
Latest Headlines
- December 22, 2011
- December 7, 2011
- November 11, 2011
- November 8, 2011
- October 14, 2011
- October 10, 2011
- October 3, 2011
- September 27, 2011
- July 12, 2011
- June 14, 2011
- June 3, 2011
- April 29, 2011
- April 21, 2011
- April 7, 2011
- April 6, 2011
- April 1, 2011
- March 31, 2011
- March 30, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
